Dexcom (DXCM) Net Income Growth (3y) (2013 - 2026)
Dexcom (DXCM) Net Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.61 Bn | 175.32 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 108.22 Bn | 99.00 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 68.29 Bn | 66.84 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.31 Bn | 27.19 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 28.03 Bn | 25.75 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 24.04 Bn | 20.91 Bn | 2.07 Bn | 280.49% |
| 10 | Steris | 21.45 Bn | 21.01 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.12% |
| Dec 31, 2025 | 42.80% |
| Sep 30, 2025 | 41.02% |
| Jun 30, 2025 | 52.30% |
| Mar 31, 2025 | 2.70% |
| Dec 31, 2024 | 212.86% |
| Sep 30, 2024 | 15.53% |
| Jun 30, 2024 | 22.32% |
| Mar 31, 2024 | 37.35% |
| Dec 31, 2023 | -14.59% |
| Sep 30, 2023 | 18.68% |
| Jun 30, 2023 | 35.78% |
| Mar 31, 2023 | 34.67% |
| Dec 31, 2022 | -0.32% |
| Sep 30, 2022 | 30.25% |
| Jun 30, 2022 | 89.89% |
| Mar 31, 2022 | 77.76% |
| Dec 31, 2021 | 69.10% |
| Sep 30, 2021 | 23.28% |
| Jun 30, 2021 | 37.44% |